The HEART Pathway Randomized Controlled Trial One-year Outcomes
- PMID: 29920834
- PMCID: PMC6934171
- DOI: 10.1111/acem.13504
The HEART Pathway Randomized Controlled Trial One-year Outcomes
Abstract
Objective: The objective was to determine the impact of the HEART Pathway on health care utilization and safety outcomes at 1 year in patients with acute chest pain.
Methods: Adult emergency department (ED) patients with chest pain (N = 282) were randomized to the HEART Pathway or usual care. In the HEART Pathway arm, ED providers used the HEART score and troponin measures (0 and 3 hours) to risk stratify patients. Usual care was based on American College of Cardiology/American Heart Association guidelines. Major adverse cardiac events (MACE-cardiac death, myocardial infarction [MI], or coronary revascularization), objective testing (stress testing or coronary angiography), and cardiac hospitalizations and ED visits were assessed at 1 year. Randomization arm outcomes were compared using Fisher's exact tests.
Results: A total of 282 patients were enrolled, with 141 randomized to each arm. MACE at 1 year occurred in 10.6% (30/282): 9.9% in the HEART Pathway arm (14/141; 10 MIs, four revascularizations without MI) versus 11.3% in usual care (16/141; one cardiac death, 13 MIs, two revascularizations without MI; p = 0.85). Among low-risk HEART Pathway patients, 0% (0/66) had MACE, with a negative predictive value (NPV) of 100% (95% confidence interval = 93%-100%). Objective testing through 1 year occurred in 63.1% (89/141) of HEART Pathway patients compared to 71.6% (101/141) in usual care (p = 0.16). Nonindex cardiac-related hospitalizations and ED visits occurred in 14.9% (21/141) and 21.3% (30/141) of patients in the HEART Pathway versus 10.6% (15/141) and 16.3% (23/141) in usual care (p = 0.37, p = 0.36).
Conclusions: The HEART Pathway had a 100% NPV for 1-year safety outcomes (MACE) without increasing downstream hospitalizations or ED visits. Reduction in 1-year objective testing was not significant.
© 2018 by the Society for Academic Emergency Medicine.
Figures
Comment in
-
In patients with chest pain, HEART Pathway-guided and usual care did not differ for MACE or health care use.Ann Intern Med. 2018 Dec 18;169(12):JC69. doi: 10.7326/ACPJC-2018-169-12-069. Ann Intern Med. 2018. PMID: 30557422 No abstract available.
References
-
- Owens PL, Barrett ML, Gibson TB, Andrews RM, Wei-nick RM, Mutter RL. Emergency department care in the United States: a profile of national data sources. Ann Emerg Med 2010;56:150–65. - PubMed
-
- Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000;342:1163–70. - PubMed
Publication types
MeSH terms
Grants and funding
- 13CRP17090055/AHA/American Heart Association-American Stroke Association/United States
- Duke Endowment/International
- 12CRP12000001/AHA/American Heart Association-American Stroke Association/United States
- Abbott Point of Care/International
- M01 RR007122/RR/NCRR NIH HHS/United States
- Roche Diagnostics/International
- Siemens by providing software for cardiac imaging research/International
- SAM is the chief medical officer of Impathiq, Inc./International
- Wake Forest Translational Science Institute/International
- L30 HL120008/HL/NHLBI NIH HHS/United States
- R01 HL118263/HL/NHLBI NIH HHS/United States
- AAMC/Donaghue Foundation/International
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
